Physician profile
Jennifer Eubank
NPI 1669555652
$1,844.24
in general payments reported to CMS, 2019-2025
18 companies · $18.32 in 2025
The $18.32 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $461 · 2022: $451 · 2023: $419 · 2024: $495 · 2025: $18.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $733 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $733.41 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $293.75 | 2021-2024 | Opzelura |
| Journey Medical Corporation | $251.07 | 2022 | |
| Janssen Biotech, INC. | $246.67 | 2021-2024 | Tremfya |
| Abbvie INC. | $243.21 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $117.02 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $109.35 | 2021-2023 | Absorica Ld, Winlevi, Ilumya |
| Genzyme Corporation | $101.96 | 2023-2024 | |
| Galderma Laboratories, L.P. | $89.93 | 2021-2024 | Oracea, Aklief |
| Lilly USA, LLC | $82.28 | 2021-2023 | Olumiant |
| E.R. Squibb & Sons, L.L.C. | $76.99 | 2023-2024 | Sotyktu |
| Ucb, INC. | $53.63 | 2021-2022 | |
| Leo Pharma INC. | $46.48 | 2021-2022 | |
| Amgen INC. | $32.33 | 2023 | Otezla, Enbrel |
| Pfizer INC. | $28.71 | 2021-2023 | |
| Blueprint Medicines Corporation | $24.75 | 2024 | Ayvakit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $18.32 | 2025 | Ycanth |
| Arcutis Biotherapeutics, INC. | $14.41 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.38 | 2024 | Jublia, Cabtreo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Eubank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.